UniProt/SwissProt ID: | HSP7C_HUMAN |
Description: | heat shock 70kDa protein 8 [Source:HGNC Symbol;Acc:5241] |
Location: | chr11 q24.1 |
Node attribute: | substrate |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
T411 | AGGVMtVLIKR | HSP70 | PhosphoSitePlus |
S153 | AYFNDsQRQAT | HPRD; phosphoELM | |
T140 | LGKTVtNAVVT | HSP70 | PhosphoSitePlus |
Y134 | EIAEAyLGKTV | HSP70 | PhosphoSitePlus |
T641 | ASSGPtIEE | HPRD | |
Y107 | KVQVEyKGETK | HSP70 | PhosphoSitePlus |
S400 | DVTPLsLGIET | HSP70 | PhosphoSitePlus |
T138 | AYLGKtVTNAV | HSP70 | PhosphoSitePlus |
S638 | SGGASsGPTIE | HPRD | |
S254 | HKKDIsENKRA | HSP70 | PhosphoSitePlus |
T502 | KENKItITNDK | HSP70 | PhosphoSitePlus |
T125 | SSMVLtKMKEI | HSP70 | PhosphoSitePlus |
T163 | TKDAGtIAGLN | HSP70 | PhosphoSitePlus |
Y107 | KVQVEyKGETK | phosphoELM | |
S277 | RTLSSsTQASI | HSP70 | PhosphoSitePlus |
Y431 | QTFTTySDNQP | HSP70 | PhosphoSitePlus |
S541 | VSSKNsLESYA | HPRD | |
T66 | MNPTNtVFDAK | HSP70 | PhosphoSitePlus |
T477 | PQIEVtFDIDA | HPRD; phosphoELM | |
S40 | NRTTPsYVAFT | HSP70 | PhosphoSitePlus |
T177 | IINEPtAAAIA | HSP70 | PhosphoSitePlus |
S221 | IFEVKsTAGDT | HSP70 | PhosphoSitePlus |
Y149 | VTVPAyFNDSQ | HSP70 | PhosphoSitePlus |
S329 | AKLDKsQIHDI | HPRD | |
T298 | FYTSItRARFE | HSP70 | PhosphoSitePlus |
T265 | VRRLRtACERA | HSP70 | PhosphoSitePlus |
S16 | LGTTYsCVGVF | HSP70 | PhosphoSitePlus |
S362 | KELNKsINPDE | HPRD | |
S254 | HKKDIsENKRA | HPRD | |
T477 | PQIEVtFDIDA | HSP70 | PhosphoSitePlus |
T341 | LVGGStRIPKI | HSP70 | PhosphoSitePlus |
T462 | GKFELtGIPPA | HPRD | |
T313 | DLFRGtLDPVE | HSP70 | PhosphoSitePlus |
Y15 | DLGTTySCVGV | HSP70 | PhosphoSitePlus |
T13 | GIDLGtTYSCV | HSP70 | PhosphoSitePlus |
Y41 | RTTPSyVAFTD | HSP70 | PhosphoSitePlus |
Y611 | IITKLyQSAGG | HPRD | |
T273 | ERAKRtLSSST | HSP70 | PhosphoSitePlus |
S637 | PSGGAsSGPTI | HPRD | |
S613 | TKLYQsAGGMP | PhosphoSitePlus | |
S385 | LSGDKsENVQD | HPRD | |
T38 | QGNRTtPSYVA | HSP70 | PhosphoSitePlus |
S541 | VSSKNsLESYA | HSP70 | PhosphoSitePlus |
Y525 | QEAEKyKAEDE | HSP70 | PhosphoSitePlus |
Y41 | RTTPSyVAFTD | phosphoELM | |
T226 | STAGDtHLGGE | HSP70 | PhosphoSitePlus |
S329 | AKLDKsQIHDI | HSP70 | PhosphoSitePlus |
S153 | AYFNDsQRQAT | HSP70 | PhosphoSitePlus |
S633 | GGAPPsGGASS | HPRD | |
S511 | DKGRLsKEDIE | HSP70 | PhosphoSitePlus |
T158 | SQRQAtKDAGT | HSP70 | PhosphoSitePlus |
S544 | KNSLEsYAFNM | HSP70 | PhosphoSitePlus |
T111 | EYKGEtKSFYP | HSP70 | PhosphoSitePlus |
T397 | LLLDVtPLSLG | HPRD | |
S362 | KELNKsINPDE | HSP70 | PhosphoSitePlus |
Dephosphorylation site |
HSP7C_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000227378 | D206G | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000227378 | I403V | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000437125 | R262C | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000437125 | D206G | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000432083 | D206G | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000432083 | R262C | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000437125 | I403V | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000432083 | I403V | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000227378 | R262C | COSMIC | Central Nervous System Neoplasms | 18772890 |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000227378 | Non-small cell lung carcinoma | Metastasis | cell line | Up | 17537172 | |
ENSP00000227378 | Leukemia | Normal vs. Cancer | cell line | Up | 9.5 | 17022645 |
ENSP00000227378 | Leukemia | Normal vs. Cancer | cell line | Up | 7.2 | 17022645 |
ENSP00000227378 | Breast Cancer | Normal vs. Cancer | cell line | Up | 3 | 14997480 |
ENSP00000227378 | Breast Cancer | Treatment (none vs. 17b-Estradiol treatment) | cell line | Up | 2.9 | 18491314 |
ENSP00000227378 | Hepatocellular Carcinoma | Normal vs. Cancer | tissue | Up | 2.4 | 11866469 |
ENSP00000227378 | hepatitis B virus | Normal vs. Cancer | tissue | Up | 3.5 | 14654528 |
ENSP00000227378 | hepatitis C virus | Normal vs. Cancer | tissue | Up | 3.5 | 14654528 |
ENSP00000227378 | Hepatocellular Carcinoma | Normal vs. Cancer | tissue | Up | 3.5 | 14654528 |
ENSP00000227378 | Hepatocellular Carcinoma | Normal vs. Cancer | tissue | Down | 0.64 | 19956837 |
ENSP00000227378 | Lung Cancer | Treatment(none vs transfected with HPV-16 E7 gene) | cell line | Up | 15684709 | |
ENSP00000227378 | Lung Cancer | Cancer vs. Cancer | cell line | Up | 17284061 | |
ENSP00000227378 | Non-small cell lung carcinoma | Treatment (none vs CIGB-300 treatment) | cell line | Down | 0.5 | 20804217 |
ENSP00000227378 | Gastric Cancer | Treatment (none vs. Vincristine-resistant) | cell line | Down | 16525997 | |
ENSP00000227378 | Gastric Cancer | Treatment (none vs. Vincristine-resistant) | cell line | Down | 0.42 | 18253933 |
ENSP00000227378 | Gastric Cancer | Normal vs. Cancer | tissue | Down | 0.23 | 19330469 |
ENSP00000227378 | Breast Cancer | Cancer vs. Cancer (Non-TNBC vs. TNBC) | cell line | Up | 20596302 | |
ENSP00000227378 | breast ductal carcinoma | Normal vs. Cancer | tissue | Up | 18564057 | |
ENSP00000227378 | Oral Cancer | Normal vs. Cancer | tissue | Up | 5.3 | 19691830 |
ENSP00000227378 | Leukemia | Cancer vs. Cancer (chronic vs. acute leukemia) | cell line | Up | 17449014 | |
ENSP00000227378 | Neoplasms by Histologic Type | Treatment (none vs. SB203580 treatment 3 hour) | cell line | Up | 5.2 | 15169874 |
ENSP00000227378 | Neoplasms by Histologic Type | Treatment (none vs. SB203580 treatment 21 hour) | cell line | Down | 0.38 | 15169874 |
ENSP00000227378 | Renal Cancer | Normal vs. Cancer | tissue | Up | 19164279 | |
ENSP00000227378 | Melanoma | Treatment (none vs. kojic acid treatment) | cell line | Down | 0.5 | 18630942 |
ENSP00000227378 | Ovarian Cancer | Metastasis | cell line | Down | 17892554 | |
ENSP00000227378 | Ovarian Cancer | Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) | cell line | Down | 0.71 | 19714814 |
ENSP00000227378 | Esophageal Cancer | Normal vs. Cancer | tissue | Down | 0.4 | 16400690 |
ENSP00000227378 | Gastric Cancer | Normal vs. Cancer | tissue | Down | 0.2 | 15761955 |
ENSP00000227378 | Uterine Cancer | Treatment(21% oxygen vs. 1% oxygen (mild hypoxia) supplemented ) | cell line | Up | 19541378 | |
ENSP00000227378 | Uterine Cancer | Treatment(21% oxygen vs. 0% oxygen (mild hypoxia) supplemented ) | cell line | Up | 19541378 | |
ENSP00000227378 | Head and Neck Cancer | Treatment(21% oxygen vs. 1% oxygen (mild hypoxia) supplemented ) | cell line | Up | 19541378 | |
ENSP00000227378 | Head and Neck Cancer | Treatment(21% oxygen vs 0% oxygen (mild hypoxia) supplemented ) | cell line | Up | 19541378 | |
ENSP00000227378 | Hepatocellular Carcinoma | Normal vs. Cancer | tissue | Up | 2 | 11866469 |
Hyperphosphorylation site |
HSP7C_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
YES_HUMAN | HSP7C_HUMAN | kinase -> substrate | Robert H Newman (2013) |
Function Annotation |
KEGG Pathway |
HSP7C_HUMAN is not in KEGG pathway. |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0005730 | nucleolus | IDA | cellular_component |
GO:0005681 | spliceosomal complex | IEA | cellular_component |
GO:0006457 | protein folding | NAS | biological_process |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0051726 | regulation of cell cycle | IEA | biological_process |
GO:0006351 | transcription, DNA-dependent | IEA | biological_process |
GO:0010467 | gene expression | TAS | biological_process |
GO:0051082 | unfolded protein binding | IEA | molecular_function |
GO:0005515 | protein binding | IEA | molecular_function |
GO:0005524 | ATP binding | IEA | molecular_function |
GO:0016071 | mRNA metabolic process | TAS | biological_process |
GO:0000974 | Prp19 complex | IDA | cellular_component |
GO:0042470 | melanosome | IEA | cellular_component |
GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transpor | TAS | cellular_component |
GO:0016044 | cellular membrane organization | TAS | biological_process |
GO:0005829 | cytosol | IEA | cellular_component |
GO:0006397 | mRNA processing | IEA | biological_process |
GO:0045892 | negative regulation of transcription, DNA-dependen | IDA | biological_process |
GO:0019048 | virus-host interaction | IEA | biological_process |
GO:0006457 | protein folding | IEA | biological_process |
GO:0000902 | cell morphogenesis | IEA | biological_process |
GO:0005622 | intracellular | NAS | cellular_component |
GO:0005622 | intracellular | IEA | cellular_component |
GO:0051085 | chaperone mediated protein folding requiring cofac | IEA | biological_process |
GO:0009986 | cell surface | IDA | cellular_component |
GO:0005886 | plasma membrane | TAS | cellular_component |
GO:0042623 | ATPase activity, coupled | IEA | molecular_function |
GO:0007268 | synaptic transmission | TAS | biological_process |
GO:0030529 | ribonucleoprotein complex | IDA | cellular_component |
GO:0005634 | nucleus | IDA | cellular_component |
GO:0008380 | RNA splicing | IEA | biological_process |
GO:0007269 | neurotransmitter secretion | TAS | biological_process |
GO:0006892 | post-Golgi vesicle-mediated transport | TAS | biological_process |
GO:0070062 | extracellular vesicular exosome | IEA | cellular_component |
GO:0006986 | response to unfolded protein | NAS | biological_process |
GO:0016070 | RNA metabolic process | TAS | biological_process |